Strikingly, there is evidence thatANLN, ECT2, PRC1,RACGAP1, ASPM, and PLK1 areupregulated in a variety of human cancers and that their overexpression oftencorrelates with poor outcome (see for example [39]-[47] and references therein). The gene discussed is PRC1; the disease is cancer.